Stock profile

Satudora Holdings Co.,Ltd.(3544.T)

Country: JapanSector: HealthcareIndustry: Medical - PharmaceuticalsExchange: JPX
P/E TTM
39.6
History
P/E NTM
N/A
Market cap
17.03B
Currency JPY
KvantraRankiN/ANot enough data to calculate KvantraRank
Value73
Quality32
MomentumN/A
Current price
1,248.00-0.08%
Benchmarks

No price history available.

Key financial summary

Financials in JPY
202020212022202320242025TTM2026E
Total revenue¥m83,24082,90587,48195,520100,174100,571N/AN/A
Operating profit¥mLockedLockedLockedLockedLockedLockedLockedLocked
Net profit¥m57531787470768434N/AN/A
EPS reported¥LockedLockedLockedLockedLockedLockedLockedLocked
Operating cashflow per share¥LockedLockedLockedLockedLockedLockedLockedLocked
Capex per share¥LockedLockedLockedLockedLockedLockedLockedLocked
FCF per share¥LockedLockedLockedLockedLockedLockedLockedLocked
Free cash flow¥mLockedLockedLockedLockedLockedLockedLockedLocked
Net debt¥mLockedLockedLockedLockedLockedLockedLockedLocked
Book value equity¥mLockedLockedLockedLockedLockedLockedLockedLocked
Book value per share¥LockedLockedLockedLockedLockedLockedLockedLocked
Number of sharesmLockedLockedLockedLockedLockedLockedLockedLocked
DPS (TTM paid)¥LockedLockedLockedLockedLockedLockedLockedLocked

Financial summary

Financials in JPY
202020212022202320242025TTM2026E
Value
P/E LTMxLockedLockedLockedLockedLockedLockedLockedLocked
P/B LTMxLockedLockedLockedLockedLockedLockedLockedLocked
P/S LTMxLockedLockedLockedLockedLockedLockedLockedLocked
P/FCF LTMxLockedLockedLockedLockedLockedLockedLockedLocked
EV/EBITDA LTMxLockedLockedLockedLockedLockedLockedLockedLocked
EV/Sales LTMxLockedLockedLockedLockedLockedLockedLockedLocked
Earnings Yield LTM%LockedLockedLockedLockedLockedLockedLockedLocked
FCF Yield%LockedLockedLockedLockedLockedLockedLockedLocked
Quality
ROE%LockedLockedLockedLockedLockedLockedLockedLocked
ROIC%LockedLockedLockedLockedLockedLockedLockedLocked
Operating margin%LockedLockedLockedLockedLockedLockedLockedLocked
Gross margin%LockedLockedLockedLockedLockedLockedLockedLocked
FCF/Sales%LockedLockedLockedLockedLockedLockedLockedLocked
Growth and momentum
EPS Growth YoY%LockedLockedLockedLockedLockedLockedLockedLocked
Sales Growth YoY%LockedLockedLockedLockedLockedLockedLockedLocked
Net Income Growth YoY%LockedLockedLockedLockedLockedLockedLockedLocked
FCF Growth%LockedLockedLockedLockedLockedLockedLockedLocked
Operating Profit Growth%LockedLockedLockedLockedLockedLockedLockedLocked
Dividend and capital structure
Dividend Yield%LockedLockedLockedLockedLockedLockedLockedLocked
Dividend Growth%LockedLockedLockedLockedLockedLockedLockedLocked
Payout Ratio%LockedLockedLockedLockedLockedLockedLockedLocked
FCF/DebtxLockedLockedLockedLockedLockedLockedLockedLocked
Net Debt/EBITDAxLockedLockedLockedLockedLockedLockedLockedLocked
EBIT/Net interestxLockedLockedLockedLockedLockedLockedLockedLocked
Net debt/market cap%LockedLockedLockedLockedLockedLockedLockedLocked
Net debt/Equity%LockedLockedLockedLockedLockedLockedLockedLocked
Gross debt/equity%LockedLockedLockedLockedLockedLockedLockedLocked

Ratings

Strong Buy
Locked
Buy
Locked
Hold
Locked
Sell
Locked
Strong Sell
Locked
Number of covering analystsLocked

Based on consensus from external analysts. Not Kvantra's opinion.

Company overview

Satudora Holdings Co., Ltd. is a Japanese enterprise primarily focused on operating drugstores and dispensing pharmacies. Its business operations are structured into two main divisions: Retail Business and IT Solution Business. Beyond its core retail activities, the company also oversees a variety of regional marketing initiatives. These include the EZOCA payment service, programming education centers for elementary and junior high school students, and the distribution of Point-of-Sale (POS) applications. Additionally, Satudora Holdings participates in wholesale trade, product development, and the energy sector. As of May 30, 2022, the company maintained a network comprising 175 drugstores, 14 other drug retail locations, 10 specialized dispensing pharmacies, and 2 different types of stores. Founded in 1972, Satudora Holdings Co., Ltd. maintains its headquarters in Sapporo, Japan.

SectorHealthcare
IndustryMedical - Pharmaceuticals
CountryJapan
Trades inJPY

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Satudora Holdings Co.,Ltd. (3544.T)

3544.T · JPX · Healthcare
1,248.00-0.08%
Sign up to track this stock

No price history available.

KvantraRankN/A
P/E TTM39.6
P/E NTMN/A
Market cap17.03B
KvantraRank?

Not enough data to calculate KvantraRank

Financialsin JPY
20242025TTM2026E
Ratings
Strong Buy
Locked
Buy
Locked
Hold
Locked
Sell
Locked
Strong Sell
Locked

Based on consensus from external analysts. Not Kvantra's opinion.

About

Satudora Holdings Co., Ltd. is a Japanese enterprise primarily focused on operating drugstores and dispensing pharmacies. Its business operations are structured into two main divisions: Retail Business and IT Solution Business. Beyond its core retail activities, the company also oversees a variety of regional marketing initiatives. These include the EZOCA payment service, programming education centers for elementary and junior high school students, and the distribution of Point-of-Sale (POS) applications. Additionally, Satudora Holdings participates in wholesale trade, product development, and the energy sector. As of May 30, 2022, the company maintained a network comprising 175 drugstores, 14 other drug retail locations, 10 specialized dispensing pharmacies, and 2 different types of stores. Founded in 1972, Satudora Holdings Co., Ltd. maintains its headquarters in Sapporo, Japan.

SectorHealthcare
IndustryMedical - Pharmaceuticals
CountryJapan
Trades inJPY

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data for this stock

Unlimited access to every company

See plans

Unlock all fundamental data for this stock

Unlimited access to every company

See plans